StockData
Encision Inc logo

Encision Inc (ECIA) stock

ECIAOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q2 FY2026, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 13, 2025Score 4/30
$0.01+0.00 (0.00%)

Close on Oct 19, 2026Market cap $163.15KP/E –Yield –

Encision r&d expenses

Research and development expenses are spending on new products and technology.

Encision's R&D Expenses for the twelve months ending Sep 30, 2025 was $665.29K, up 2.8% year over year. For fiscal 2025 it was $593.15K, down 4.6% from the year before. Over ten years it grew -7.8% a year on average. The highest annual figure on record is $1.76M in fiscal 2013.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Mar 31, 2025$593.15K-4.6%
FY2024Mar 31, 2024$621.89K-23.8%
FY2023Mar 31, 2023$816.12K-11.1%
FY2022Mar 31, 2022$918.16K+61.2%
FY2021Mar 31, 2021$569.54K-23.9%
FY2020Mar 31, 2020$748.39K-4.0%
FY2019Mar 31, 2019$779.49K-7.4%
FY2018Mar 31, 2018$842.08K-25.3%
FY2017Mar 31, 2017$1.13M-9.9%
FY2016Mar 31, 2016$1.25M-6.9%
FY2015Mar 31, 2015$1.34M-4.6%
FY2014Mar 31, 2014$1.41M-19.9%
FY2013Mar 31, 2013$1.76M+30.1%
FY2012Mar 31, 2012$1.35M-7.8%
FY2011Mar 31, 2011$1.46M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ3 2025Sep 30, 2025$201.39K+29.5%
Q1 FY2026CQ2 2025Jun 30, 2025$165.44K+18.9%
Q4 FY2025CQ1 2025Mar 31, 2025$159.65K-20.8%
Q3 FY2025CQ4 2024Dec 31, 2024$138.80K-8.1%
Q2 FY2025CQ3 2024Sep 30, 2024$155.52K+54.2%
Q1 FY2025CQ2 2024Jun 30, 2024$139.18K-17.4%
Q4 FY2024CQ1 2024Mar 31, 2024$201.54K+15.1%
Q3 FY2024CQ4 2023Dec 31, 2023$151.08K-39.0%
Q2 FY2024CQ3 2023Sep 30, 2023$100.85K-54.8%
Q1 FY2024CQ2 2023Jun 30, 2023$168.42K-1.2%
Q4 FY2023CQ1 2023Mar 31, 2023$175.03K-47.6%
Q3 FY2023CQ4 2022Dec 31, 2022$247.57K+27.5%
Q2 FY2023CQ3 2022Sep 30, 2022$223.05K+4.6%
Q1 FY2023CQ2 2022Jun 30, 2022$170.47K-3.6%
Q4 FY2022CQ1 2022Mar 31, 2022$333.99K+164.9%
Q3 FY2022CQ4 2021Dec 31, 2021$194.12K+39.3%
Q2 FY2022CQ3 2021Sep 30, 2021$213.16K+31.2%
Q1 FY2022CQ2 2021Jun 30, 2021$176.88K+24.9%
Q4 FY2021CQ1 2021Mar 31, 2021$126.09K-30.2%
Q3 FY2021CQ4 2020Dec 31, 2020$139.39K-12.3%
Q2 FY2021CQ3 2020Sep 30, 2020$162.46K-5.9%
Q1 FY2021CQ2 2020Jun 30, 2020$141.61K-40.0%
Q4 FY2020CQ1 2020Mar 31, 2020$180.64K-23.7%
Q3 FY2020CQ4 2019Dec 31, 2019$158.94K-16.1%
Q2 FY2020CQ3 2019Sep 30, 2019$172.67K-7.5%
Q1 FY2020CQ2 2019Jun 30, 2019$236.14K+41.7%
Q4 FY2019CQ1 2019Mar 31, 2019$236.89K+14.5%
Q3 FY2019CQ4 2018Dec 31, 2018$189.35K-15.5%
Q2 FY2019CQ3 2018Sep 30, 2018$186.58K-1.7%
Q1 FY2019CQ2 2018Jun 30, 2018$166.67K-24.7%
Q4 FY2018CQ1 2018Mar 31, 2018$206.92K-15.8%
Q3 FY2018CQ4 2017Dec 31, 2017$223.98K-25.4%
Q2 FY2018CQ3 2017Sep 30, 2017$189.86K-31.9%
Q1 FY2018CQ2 2017Jun 30, 2017$221.33K-26.6%
Q4 FY2017CQ1 2017Mar 31, 2017$245.87K-23.3%
Q3 FY2017CQ4 2016Dec 31, 2016$300.39K-11.6%
Q2 FY2017CQ3 2016Sep 30, 2016$278.72K–
Q1 FY2017CQ2 2016Jun 30, 2016$301.65K–
Q4 FY2016CQ1 2016Mar 31, 2016$320.39K–
Q3 FY2016CQ4 2015Dec 31, 2015$339.75K–

More Encision figures

See a number that looks wrong?